SANGAMO THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 146.50 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-14
- SANGAMO THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 146.50M shares, a 164.92% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 98.40M shares, a 674.80% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 100.00M shares, a 88.32% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 55.30M shares, a 0.54% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 96.50M shares, a 91.09% increase from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 50.50M shares, a 137.09% increase from fiscal 2023.
- SANGAMO THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 21.30M shares, a 14.76% increase from fiscal 2022.
- SANGAMO THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 18.56M shares, a 22.43% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 146.50M shares 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | 96.50M shares 10-K · filed 2026-03-30 | |||||||
| 2025-09-30 | 98.40M shares 10-Q · filed 2025-11-06 | 98.40M shares 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | 100.00M shares 10-Q · filed 2025-08-07 | 100.00M shares 10-Q · filed 2025-08-07 | ||||||
| 2025-03-31 | 55.30M shares 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | 50.50M shares 10-K · filed 2026-03-30 | |||||||
| 2024-09-30 | 12.70M shares 10-Q · filed 2025-11-06 | 51.60M shares 10-Q · filed 2025-11-06 | ||||||
| 2024-06-30 | 53.10M shares 10-Q · filed 2025-08-07 | 53.10M shares 10-Q · filed 2025-08-07 | ||||||
| 2024-03-31 | 55.60M shares 10-Q · filed 2025-05-12 | |||||||
| 2023-12-31 | 21.30M shares 10-K · filed 2025-03-17 | 21.25M shares 10-K · filed 2024-03-13 | ||||||
| 2023-09-30 | 22.10M shares 10-Q · filed 2024-11-12 | 22.10M shares 10-Q · filed 2024-11-12 | 22.13M shares 10-Q · filed 2023-11-01 | |||||
| 2023-06-30 | 24.30M shares 10-Q · filed 2024-08-06 | 24.30M shares 10-Q · filed 2024-08-06 | 24.33M shares 10-Q · filed 2023-08-08 | |||||
| 2023-03-31 | 14.70M shares 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | 18.56M shares 10-K · filed 2024-03-13 | |||||||
| 2022-09-30 | 18.52M shares 10-Q · filed 2023-11-01 | |||||||
| 2022-06-30 | 18.68M shares 10-Q · filed 2023-08-08 | |||||||
| 2022-03-31 | 19.10M shares 10-Q · filed 2023-05-08 | 19.13M shares 10-Q · filed 2022-05-05 | ||||||
| 2021-12-31 | 15.16M shares 10-K · filed 2024-03-13 | |||||||
| 2021-09-30 | 15.84M shares 10-Q · filed 2022-11-03 | |||||||
| 2021-06-30 | 16.98M shares 10-Q · filed 2022-08-04 | |||||||
| 2021-03-31 | 17.61M shares 10-Q · filed 2022-05-05 | |||||||
| 2020-09-30 | 14.77M shares 10-Q · filed 2021-11-04 | |||||||
| 2020-06-30 | 14.96M shares 10-Q · filed 2021-08-05 | |||||||
| 2020-03-31 | 14.85M shares 10-Q · filed 2021-05-04 | |||||||
| 2019-12-31 | 10.16M shares 10-Q · filed 2020-08-05 | |||||||
| 2019-09-30 | 10.37M shares 10-Q · filed 2020-11-04 | |||||||
| 2019-03-31 | 11.60M shares 10-Q · filed 2020-05-11 | |||||||
| 2014-06-30 | 7.24M shares 10-Q · filed 2014-07-29 | |||||||
| 2014-03-31 | 7.30M shares 10-Q · filed 2014-05-07 | |||||||
| 2013-09-30 | 7.85M shares 10-Q · filed 2013-11-04 | |||||||
| 2013-06-30 | 8.34M shares 10-Q · filed 2013-08-02 | 8.34M shares 10-Q · filed 2014-07-29 | ||||||
| 2013-03-31 | 8.66M shares 10-Q · filed 2014-05-07 | |||||||
| 2012-12-31 | 9.18M shares 10-K · filed 2013-02-26 | |||||||
| 2012-09-30 | 8.08M shares 10-Q · filed 2012-11-02 | 8.08M shares 10-Q · filed 2013-11-04 | 8.07M shares 10-Q · filed 2012-11-02 | |||||
| 2012-06-30 | 8.23M shares 10-Q · filed 2013-08-02 | 8.24M shares 10-Q · filed 2012-08-03 | 8.23M shares 10-Q · filed 2013-08-02 | 7.89M shares 10-Q · filed 2012-08-03 | ||||
| 2012-03-31 | 8.29M shares 10-Q · filed 2013-05-09 | |||||||
| 2011-12-31 | 8.35M shares 10-K · filed 2013-02-26 | |||||||
| 2011-09-30 | 8.08M shares 10-Q · filed 2012-11-02 | 8.07M shares 10-Q · filed 2012-11-02 | ||||||
| 2011-06-30 | 8.24M shares 10-Q · filed 2012-08-03 | 7.89M shares 10-Q · filed 2012-08-03 | ||||||
| 2010-12-31 | 8.11M shares 10-K · filed 2013-02-26 |